Category: Drug Discovery
Global Drug Discovery
-
Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography
... Research laboratories) and Geography According to Stratistics MRC, the Global Therapeutic Enzymes Market is accounted for $8467.9 million in 2022 and is expected to reach $18684.8 million by 2028 growing at a CAGR of 14.1% ... Read More
-
Brain Tumor Drugs Market Forecasts to 2028 - Global Analysis By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy and Other Therapies), Indication (Pituitary Tumors, Meningioma, Glioblastoma and Glioma), Drugs (Bevacizumab, Temozolomide and Other Drugs) and Geography
... to Stratistics MRC, the Global Brain Tumor Drugs Market is accounted for $2.56 billion in 2022 and is expected to reach $4.80 billion by 2028 growing at a CAGR of 11.0% during the forecast period. ... Read More
-
Retina Health Market Forecast till 2030
... the back of the eye that transforms light entering the eye into electrical signals that the brain may process into images. The prevention of vision problems and even blindness depends on a healthy retina. The ... Read More
-
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage ... Read More
-
DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research And Development, Therapeutics), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a ... Read More
-
Global Alzheimer’s Therapeutics Market Size, Trends & Growth Opportunity, By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user (Hospital Pharmacy, Retail Pharmacy, E-commerce), Forecast till 2027.
... global Alzheimer’s Therapeutics Market was valued at USD 4.20 billion in 2021 which expected to reach USD 15.6 billion by 2027 at a CAGR 16.2% from 2020-2027 Qualiket Market Research covers topics such as worldwide ... Read More
-
Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million ... Read More
-
Dementia and Alzheimer’s Disease Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... increasing cases of Alzheimer's and dementia coupled with growing awareness regarding the diseases are bolstering the growth of the market. Moreover, elderly population are more prone to such diseases due to growing age, which in ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
... Therapeutics estimated at US$ 15,175.51 million in the year 2022, is projected to reach a revised size of US$ 28,717.44 million by 2028, growing at a CAGR of 11.22% during the forecast period 2022-2028. The ... Read More
-
Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028
... Dermatitis Drugs Market size is expected to reach $22 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period. Eczema, commonly referred to as atopic dermatitis, is a skin ailment ... Read More
-
Global Biosimulation Market (2022 Edition) – Analysis By Component (Software, Service), Application (Drug Discovery, Pre-Clinical, Clinical), End-User, By Region, By Country: Market Insights and Forecast (2018-2028)
... Azoth Analytics in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase the probability of success in human clinical trials, the most expensive part ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes ... Read More
-
Acne Vulgaris Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Acne Vulgaris Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Neglected Tropical Disease Treatment Market - 2022-2029
... growing at a CAGR of 5.55% during the forecast period (2022-2029). Neglected tropical diseases (NTDs) are a series of 20 diseases mostly found in tropical areas, disproportionately impacting poor people, women and children. People suffer ... Read More
-
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Restless Legs Syndrome Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Benign Prostatic Hyperplasia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Benign Prostatic Hyperplasia Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Global Tuberculosis Drugs Market - 2022-2029
... of 9.68% during the forecast period (2022-2029). Tuberculosis (TB), known as poor man’s disease, is caused by mycobacterium tuberculosis germs spread from person to person through the air. Tuberculosis drugs are also used post surgeries ... Read More
-
Global Diffuse Large B-cell Lymphoma Therapeutics Market - 2022-2029
... by 2028, growing at a CAGR of 7.50 % during the forecast period (2022-2029). Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). DLBCL is an aggressive (fast-growing) NHL that ... Read More
-
mRNA Therapeutics - Thematic Intelligence
... are no current regulatory guidelines that dictate the approval and development process for mRNA therapeutics. They are instead regulated as gene therapies. mRNA therapeutics must overcome barriers with delivery in order to be successful. Key ... Read More
-
Lab Automation Market Size, Share & Trends Report, 2022-2030
... of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Lab Automation market size is growing at a CAGR of 8.54% during the forecast ... Read More
-
mRNA Vaccines and Therapeutics Market Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030
... on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The ... Read More
-
Global Contract Research Organization (CRO) Growth Opportunities
... either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and emerging biopharma participants introducing novel therapies across various indications, primarily oncology, infectious ... Read More
-
Global Plasmid DNA Manufacturing Market Size study & Forecast, by Grade (R&D Grade, GMP Grade), by Development (Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics), by Application (DNA Vaccines, Cell & Gene Therapy, Immunotherapy, Others), by Disease (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029
... (Infectious Disease, Cancer, Genetic Disorder) and Regional Analysis, 2022-2029 Global Plasmid DNA Manufacturing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Pneumonia Therapeutics Market Size study & Forecast, by Therapeutics (Prevention Vaccines and Treatment Drugs), by Distribution Channel (Hospitals, Pharmaceutical Stores, and Others), and by Age Group (Pediatric, Adult, and Geriatric) and Regional Analysis, 2022-2029
... Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type ... Read More
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Biopharma Production, Research, Diagnostics), End User (Biotech, CROs) - Global Forecast to 2027
... is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period. The market growth is primarily driven by factors such as increasing ... Read More
Research Assistance
